Haner Di̇reskeneli̇

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2002 · 1.1K citations · Full text

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

Bhaskar Dasgupta, Marco A. Cimmino, Hilal Maradit Kremers et al. · Annals of the Rheumatic Diseases · 2012 · 632 citations · Full text

Rheumatology, Rheumatic Diseases, Chronic Musculoskeletal Condition +7

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, D. D’Cruz et al. · Annals of the Rheumatic Diseases · 2009 · 528 citations

2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

Bhaskar Dasgupta, Marco A. Cimmino, Hilal Maradit Kremers et al. · Arthritis & Rheumatism · 2012 · 396 citations · Full text

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2004 · 382 citations · Full text